Reduction in Peripheral CD19+CD24hCD27+ B Cell Frequency Predicts Favourable Clinical Course in XELOX-Treated Patients with Advanced Gastric Cancer (Q40238014)
Jump to navigation
Jump to search
scientific article published on 14 April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction in Peripheral CD19+CD24hCD27+ B Cell Frequency Predicts Favourable Clinical Course in XELOX-Treated Patients with Advanced Gastric Cancer |
scientific article published on 14 April 2017 |
Statements
1 reference
Reduction in Peripheral CD19+CD24hCD27+ B Cell Frequency Predicts Favourable Clinical Course in XELOX-Treated Patients with Advanced Gastric Cancer (English)
1 reference
Wei Li
1 reference
Dongli Song
1 reference
Hong Li
1 reference
Li Liang
1 reference
Naiqing Zhao
1 reference
Tianshu Liu
1 reference
14 April 2017
1 reference
1 reference
Identifiers
1 reference